世界のてんかん発作治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Epileptic Seizures Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4199
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、てんかん発作治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬、個別療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・てんかん発作治療の市場動向
・企業の競争状況、市場シェア
・てんかん発作治療の種類別市場規模と予測2016-2027（治療法、新薬、個別療法）
・てんかん発作治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・てんかん発作治療の北米市場規模2016-2027（アメリカ、カナダ）
・てんかん発作治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・てんかん発作治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・てんかん発作治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・てんかん発作治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bausch Health Companies, Inc.、GlaxoSmithKline plc.、UCB S.A.、Pfizer, Inc.、Apotex, Inc.、Alexza Pharmaceuticals, Inc.、Neurelis, Inc.、Veriton Pharma）
・結論

Epilepsy is a disorder of the brain characterized by repeated seizures. A seizure is usually defined as a sudden alteration of behavior due to a temporary change in the electrical functioning of the brain. Normally, the brain continuously generates tiny electrical impulses in an orderly pattern. These impulses travel along neurons – the network of nerve cells in the brain – and throughout the whole body via chemical messengers called neurotransmitters. In epilepsy, the brain’s electrical rhythms tend to become imbalanced, resulting in recurrent seizures. Moreover, in patients with seizures, the normal electrical pattern is disrupted by sudden and synchronized bursts of electrical energy that may briefly affect their consciousness, movements, or sensations.

Market Analysis and Insights: Global Epileptic Seizures Treatment Market
The global Epileptic Seizures Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epileptic Seizures Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epileptic Seizures Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epileptic Seizures Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epileptic Seizures Treatment market.

Global Epileptic Seizures Treatment Scope and Market Size
Epileptic Seizures Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epileptic Seizures Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Treatment Practices
Emerging Drugs
Individual Therapies

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health Companies, Inc.
GlaxoSmithKline plc.
UCB S.A.
Pfizer, Inc.
Apotex, Inc.
Alexza Pharmaceuticals, Inc.
Neurelis, Inc.
Veriton Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epileptic Seizures Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Treatment Practices
1.2.3 Emerging Drugs
1.2.4 Individual Therapies
1.3 Market by Application
1.3.1 Global Epileptic Seizures Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epileptic Seizures Treatment Market Perspective (2016-2027)
2.2 Epileptic Seizures Treatment Growth Trends by Regions
2.2.1 Epileptic Seizures Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epileptic Seizures Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Epileptic Seizures Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Epileptic Seizures Treatment Industry Dynamic
2.3.1 Epileptic Seizures Treatment Market Trends
2.3.2 Epileptic Seizures Treatment Market Drivers
2.3.3 Epileptic Seizures Treatment Market Challenges
2.3.4 Epileptic Seizures Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epileptic Seizures Treatment Players by Revenue
3.1.1 Global Top Epileptic Seizures Treatment Players by Revenue (2016-2021)
3.1.2 Global Epileptic Seizures Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Epileptic Seizures Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epileptic Seizures Treatment Revenue
3.4 Global Epileptic Seizures Treatment Market Concentration Ratio
3.4.1 Global Epileptic Seizures Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epileptic Seizures Treatment Revenue in 2020
3.5 Epileptic Seizures Treatment Key Players Head office and Area Served
3.6 Key Players Epileptic Seizures Treatment Product Solution and Service
3.7 Date of Enter into Epileptic Seizures Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epileptic Seizures Treatment Breakdown Data by Type
4.1 Global Epileptic Seizures Treatment Historic Market Size by Type (2016-2021)
4.2 Global Epileptic Seizures Treatment Forecasted Market Size by Type (2022-2027)

5 Epileptic Seizures Treatment Breakdown Data by Application
5.1 Global Epileptic Seizures Treatment Historic Market Size by Application (2016-2021)
5.2 Global Epileptic Seizures Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Epileptic Seizures Treatment Market Size (2016-2027)
6.2 North America Epileptic Seizures Treatment Market Size by Type
6.2.1 North America Epileptic Seizures Treatment Market Size by Type (2016-2021)
6.2.2 North America Epileptic Seizures Treatment Market Size by Type (2022-2027)
6.2.3 North America Epileptic Seizures Treatment Market Size by Type (2016-2027)
6.3 North America Epileptic Seizures Treatment Market Size by Application
6.3.1 North America Epileptic Seizures Treatment Market Size by Application (2016-2021)
6.3.2 North America Epileptic Seizures Treatment Market Size by Application (2022-2027)
6.3.3 North America Epileptic Seizures Treatment Market Size by Application (2016-2027)
6.4 North America Epileptic Seizures Treatment Market Size by Country
6.4.1 North America Epileptic Seizures Treatment Market Size by Country (2016-2021)
6.4.2 North America Epileptic Seizures Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Epileptic Seizures Treatment Market Size (2016-2027)
7.2 Europe Epileptic Seizures Treatment Market Size by Type
7.2.1 Europe Epileptic Seizures Treatment Market Size by Type (2016-2021)
7.2.2 Europe Epileptic Seizures Treatment Market Size by Type (2022-2027)
7.2.3 Europe Epileptic Seizures Treatment Market Size by Type (2016-2027)
7.3 Europe Epileptic Seizures Treatment Market Size by Application
7.3.1 Europe Epileptic Seizures Treatment Market Size by Application (2016-2021)
7.3.2 Europe Epileptic Seizures Treatment Market Size by Application (2022-2027)
7.3.3 Europe Epileptic Seizures Treatment Market Size by Application (2016-2027)
7.4 Europe Epileptic Seizures Treatment Market Size by Country
7.4.1 Europe Epileptic Seizures Treatment Market Size by Country (2016-2021)
7.4.2 Europe Epileptic Seizures Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Epileptic Seizures Treatment Market Size (2016-2027)
8.2 Asia-Pacific Epileptic Seizures Treatment Market Size by Type
8.2.1 Asia-Pacific Epileptic Seizures Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epileptic Seizures Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epileptic Seizures Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Epileptic Seizures Treatment Market Size by Application
8.3.1 Asia-Pacific Epileptic Seizures Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epileptic Seizures Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epileptic Seizures Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Epileptic Seizures Treatment Market Size by Region
8.4.1 Asia-Pacific Epileptic Seizures Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epileptic Seizures Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Epileptic Seizures Treatment Market Size (2016-2027)
9.2 Latin America Epileptic Seizures Treatment Market Size by Type
9.2.1 Latin America Epileptic Seizures Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Epileptic Seizures Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Epileptic Seizures Treatment Market Size by Type (2016-2027)
9.3 Latin America Epileptic Seizures Treatment Market Size by Application
9.3.1 Latin America Epileptic Seizures Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Epileptic Seizures Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Epileptic Seizures Treatment Market Size by Application (2016-2027)
9.4 Latin America Epileptic Seizures Treatment Market Size by Country
9.4.1 Latin America Epileptic Seizures Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Epileptic Seizures Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Epileptic Seizures Treatment Market Size (2016-2027)
10.2 Middle East & Africa Epileptic Seizures Treatment Market Size by Type
10.2.1 Middle East & Africa Epileptic Seizures Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epileptic Seizures Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epileptic Seizures Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Epileptic Seizures Treatment Market Size by Application
10.3.1 Middle East & Africa Epileptic Seizures Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epileptic Seizures Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epileptic Seizures Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Epileptic Seizures Treatment Market Size by Country
10.4.1 Middle East & Africa Epileptic Seizures Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epileptic Seizures Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health Companies, Inc.
11.1.1 Bausch Health Companies, Inc. Company Details
11.1.2 Bausch Health Companies, Inc. Business Overview
11.1.3 Bausch Health Companies, Inc. Epileptic Seizures Treatment Introduction
11.1.4 Bausch Health Companies, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.1.5 Bausch Health Companies, Inc. Recent Development
11.2 GlaxoSmithKline plc.
11.2.1 GlaxoSmithKline plc. Company Details
11.2.2 GlaxoSmithKline plc. Business Overview
11.2.3 GlaxoSmithKline plc. Epileptic Seizures Treatment Introduction
11.2.4 GlaxoSmithKline plc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline plc. Recent Development
11.3 UCB S.A.
11.3.1 UCB S.A. Company Details
11.3.2 UCB S.A. Business Overview
11.3.3 UCB S.A. Epileptic Seizures Treatment Introduction
11.3.4 UCB S.A. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.3.5 UCB S.A. Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Epileptic Seizures Treatment Introduction
11.4.4 Pfizer, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.4.5 Pfizer, Inc. Recent Development
11.5 Apotex, Inc.
11.5.1 Apotex, Inc. Company Details
11.5.2 Apotex, Inc. Business Overview
11.5.3 Apotex, Inc. Epileptic Seizures Treatment Introduction
11.5.4 Apotex, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.5.5 Apotex, Inc. Recent Development
11.6 Alexza Pharmaceuticals, Inc.
11.6.1 Alexza Pharmaceuticals, Inc. Company Details
11.6.2 Alexza Pharmaceuticals, Inc. Business Overview
11.6.3 Alexza Pharmaceuticals, Inc. Epileptic Seizures Treatment Introduction
11.6.4 Alexza Pharmaceuticals, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.6.5 Alexza Pharmaceuticals, Inc. Recent Development
11.7 Neurelis, Inc.
11.7.1 Neurelis, Inc. Company Details
11.7.2 Neurelis, Inc. Business Overview
11.7.3 Neurelis, Inc. Epileptic Seizures Treatment Introduction
11.7.4 Neurelis, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.7.5 Neurelis, Inc. Recent Development
11.8 Veriton Pharma
11.8.1 Veriton Pharma Company Details
11.8.2 Veriton Pharma Business Overview
11.8.3 Veriton Pharma Epileptic Seizures Treatment Introduction
11.8.4 Veriton Pharma Revenue in Epileptic Seizures Treatment Business (2016-2021)
11.8.5 Veriton Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epileptic Seizures Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Treatment Practices
Table 3. Key Players of Emerging Drugs
Table 4. Key Players of Individual Therapies
Table 5. Global Epileptic Seizures Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Epileptic Seizures Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Epileptic Seizures Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Epileptic Seizures Treatment Market Share by Regions (2016-2021)
Table 9. Global Epileptic Seizures Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Epileptic Seizures Treatment Market Share by Regions (2022-2027)
Table 11. Epileptic Seizures Treatment Market Trends
Table 12. Epileptic Seizures Treatment Market Drivers
Table 13. Epileptic Seizures Treatment Market Challenges
Table 14. Epileptic Seizures Treatment Market Restraints
Table 15. Global Epileptic Seizures Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Epileptic Seizures Treatment Market Share by Players (2016-2021)
Table 17. Global Top Epileptic Seizures Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epileptic Seizures Treatment as of 2020)
Table 18. Ranking of Global Top Epileptic Seizures Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Epileptic Seizures Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Epileptic Seizures Treatment Product Solution and Service
Table 22. Date of Enter into Epileptic Seizures Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Epileptic Seizures Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Epileptic Seizures Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Epileptic Seizures Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Epileptic Seizures Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Epileptic Seizures Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Epileptic Seizures Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Epileptic Seizures Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Epileptic Seizures Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Epileptic Seizures Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Epileptic Seizures Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Epileptic Seizures Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Epileptic Seizures Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Epileptic Seizures Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Epileptic Seizures Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Epileptic Seizures Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Epileptic Seizures Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Epileptic Seizures Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Epileptic Seizures Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epileptic Seizures Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epileptic Seizures Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epileptic Seizures Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Epileptic Seizures Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Epileptic Seizures Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Epileptic Seizures Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Epileptic Seizures Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Epileptic Seizures Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Epileptic Seizures Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Epileptic Seizures Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Epileptic Seizures Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epileptic Seizures Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epileptic Seizures Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epileptic Seizures Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Epileptic Seizures Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bausch Health Companies, Inc. Company Details
Table 63. Bausch Health Companies, Inc. Business Overview
Table 64. Bausch Health Companies, Inc. Epileptic Seizures Treatment Product
Table 65. Bausch Health Companies, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 66. Bausch Health Companies, Inc. Recent Development
Table 67. GlaxoSmithKline plc. Company Details
Table 68. GlaxoSmithKline plc. Business Overview
Table 69. GlaxoSmithKline plc. Epileptic Seizures Treatment Product
Table 70. GlaxoSmithKline plc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline plc. Recent Development
Table 72. UCB S.A. Company Details
Table 73. UCB S.A. Business Overview
Table 74. UCB S.A. Epileptic Seizures Treatment Product
Table 75. UCB S.A. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 76. UCB S.A. Recent Development
Table 77. Pfizer, Inc. Company Details
Table 78. Pfizer, Inc. Business Overview
Table 79. Pfizer, Inc. Epileptic Seizures Treatment Product
Table 80. Pfizer, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 81. Pfizer, Inc. Recent Development
Table 82. Apotex, Inc. Company Details
Table 83. Apotex, Inc. Business Overview
Table 84. Apotex, Inc. Epileptic Seizures Treatment Product
Table 85. Apotex, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 86. Apotex, Inc. Recent Development
Table 87. Alexza Pharmaceuticals, Inc. Company Details
Table 88. Alexza Pharmaceuticals, Inc. Business Overview
Table 89. Alexza Pharmaceuticals, Inc. Epileptic Seizures Treatment Product
Table 90. Alexza Pharmaceuticals, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 91. Alexza Pharmaceuticals, Inc. Recent Development
Table 92. Neurelis, Inc. Company Details
Table 93. Neurelis, Inc. Business Overview
Table 94. Neurelis, Inc. Epileptic Seizures Treatment Product
Table 95. Neurelis, Inc. Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 96. Neurelis, Inc. Recent Development
Table 97. Veriton Pharma Company Details
Table 98. Veriton Pharma Business Overview
Table 99. Veriton Pharma Revenue in Epileptic Seizures Treatment Business (2016-2021) & (US$ Million)
Table 100. Veriton Pharma Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epileptic Seizures Treatment Market Share by Type: 2020 VS 2027
Figure 2. Treatment Practices Features
Figure 3. Emerging Drugs Features
Figure 4. Individual Therapies Features
Figure 5. Global Epileptic Seizures Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Epileptic Seizures Treatment Report Years Considered
Figure 10. Global Epileptic Seizures Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Epileptic Seizures Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Epileptic Seizures Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Epileptic Seizures Treatment Market Share by Regions (2022-2027)
Figure 14. Global Epileptic Seizures Treatment Market Share by Players in 2020
Figure 15. Global Top Epileptic Seizures Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epileptic Seizures Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Epileptic Seizures Treatment Revenue in 2020
Figure 17. Global Epileptic Seizures Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Epileptic Seizures Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Epileptic Seizures Treatment Market Share by Type (2016-2027)
Figure 21. North America Epileptic Seizures Treatment Market Share by Application (2016-2027)
Figure 22. North America Epileptic Seizures Treatment Market Share by Country (2016-2027)
Figure 23. United States Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epileptic Seizures Treatment Market Share by Type (2016-2027)
Figure 27. Europe Epileptic Seizures Treatment Market Share by Application (2016-2027)
Figure 28. Europe Epileptic Seizures Treatment Market Share by Country (2016-2027)
Figure 29. Germany Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epileptic Seizures Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Epileptic Seizures Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Epileptic Seizures Treatment Market Share by Region (2016-2027)
Figure 39. China Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epileptic Seizures Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Epileptic Seizures Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Epileptic Seizures Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epileptic Seizures Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Epileptic Seizures Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Epileptic Seizures Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Epileptic Seizures Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bausch Health Companies, Inc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 59. GlaxoSmithKline plc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 60. UCB S.A. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 61. Pfizer, Inc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 62. Apotex, Inc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 63. Alexza Pharmaceuticals, Inc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 64. Neurelis, Inc. Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 65. Veriton Pharma Revenue Growth Rate in Epileptic Seizures Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Global Developmental and Epileptic Encephalopathies (DEE) Market Size, Status and Forecast 2021-2027
QFJ1-4117 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、発達性＆てんかん性脳症（DEE）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小児用非定型良性部分てんかん、ドラベト症候群、徐波睡眠時連続スパイク・アンド・ウェーブ発生型てんかん、視床下部てんかん、...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の発達性＆てんかん性脳症（DEE）市場規模・現状・予測（2021年-2027年） Developmental and Epileptic Encephalopathies (DEE) consists of several types of severe brain disorders in which the epileptic electrical discharges may add to progressive psychomotor dysfunction. They are a group of nosologies that are related to an early age and manifest with electroencephalography…
てんかん発作用モニター警報システムのグローバル市場2021 Epileptic Seizure Monitor Alarm System is a seizure-detection system that can be used long-term and in home situations for early intervention and prevention of seizure related side effects including SUDEP (sudden unexpected death in epileptic patients). The classification of epileptic seizure monito…
世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界の副鼻腔炎治療薬市場規模・現状・予測（2021年-2027年） Sinusitis is an inflammation or swelling of the tissue lining the sinuses. Market Analysis and Insights: Global Sinusitis Treatment Drugs Market The global Sinusitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…